Burkhard Göke

25.3k total citations · 2 hit papers
423 papers, 20.1k citations indexed

About

Burkhard Göke is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Burkhard Göke has authored 423 papers receiving a total of 20.1k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Surgery, 135 papers in Endocrinology, Diabetes and Metabolism and 112 papers in Molecular Biology. Recurrent topics in Burkhard Göke's work include Diabetes Treatment and Management (107 papers), Pancreatic function and diabetes (84 papers) and Neuropeptides and Animal Physiology (47 papers). Burkhard Göke is often cited by papers focused on Diabetes Treatment and Management (107 papers), Pancreatic function and diabetes (84 papers) and Neuropeptides and Animal Physiology (47 papers). Burkhard Göke collaborates with scholars based in Germany, United States and Switzerland. Burkhard Göke's co-authors include Rüdiger Göke, Stephan Brand, Thomas Ochsenkühn, Christoph J. Auernhammer, Frank T. Kolligs, Rudolf Arnold, H. C. Fehmann, Florian Beigel, Jörg Schirra and R. Arnold and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Burkhard Göke

417 papers receiving 19.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

1993 695 citations Rüdiger Göke, Harald Schmidt et al. Journal of Biological Chemistry profile →
Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man

1992 512 citations Rüdiger Göke, Burkhard Göke et al. profile →

Peers

Countries citing papers authored by Burkhard Göke

Since Specialization

Citations

This map shows the geographic impact of Burkhard Göke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkhard Göke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkhard Göke more than expected).

Fields of papers citing papers by Burkhard Göke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkhard Göke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkhard Göke. The network helps show where Burkhard Göke may publish in the future.

Co-authorship network of co-authors of Burkhard Göke

This figure shows the co-authorship network connecting the top 25 collaborators of Burkhard Göke. A scholar is included among the top collaborators of Burkhard Göke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkhard Göke. Burkhard Göke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glucagon receptor family in GtoPdb v.2025.3 2025 ·IUPHAR/BPS Guide to Pharmacology CITE ·D. Bataille, Roberto Salvatori, Laurence J. Miller, Kelly E. Mayo, Rebecca Hills, Burkhard Göke, Daniel J. Drucker, Philippe Delagrange, Susan L.F. Chan, Bernard Thorens	0
2	DRO1 Inactivation Drives Colorectal Carcinogenesis in ApcMin /+ Mice 2014 ·Molecular Cancer Research ·(unknown), Jens Neumann, (unknown), (unknown), (unknown), (unknown), Eckhard Wolf, Thomas Kirchner, Burkhard Göke, Marlon R. Schneider, Frank T. Kolligs	17
3	Intestinal DMBT1 Expression Is Modulated by Crohn’s Disease-Associated IL23R Variants and by a DMBT1 Variant Which Influences Binding of the Transcription Factors CREB1 and ATF-2 2013 ·PLoS ONE ·Julia Diegelmann, Darina Czamara, (unknown), Eva Zimmermann, Torsten Olszak, Andrea Bedynek, Burkhard Göke, André Franke, Jürgen Glas, Stephan Brand	22
4	The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes 2012 ·Diabetes ·Hans J. Woerle, (unknown), (unknown), Burkhard Göke, Jörg Schirra	64
5	Changing Metabolic Signatures of Amino Acids and Lipids During the Prediabetic Period in a Pig Model With Impaired Incretin Function and Reduced β-Cell Mass 2012 ·Diabetes ·Simone Renner, Werner Römisch‐Margl, Cornelia Prehn, Stefan Krebs, Jerzy Adamski, Burkhard Göke, Helmut Blum, Karsten Suhre, Adelbert A. Roscher, Eckhard Wolf	39
6	Risk factors for advanced neoplasia within subcentimetric polyps: implications for diagnostic imaging 2012 ·Gut ·Frank T. Kolligs, Alexander Crispin, Anno Graser, (unknown), Ulrich Mansmann, Burkhard Göke	16
7	Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis 2010 ·The American Journal of Gastroenterology ·Matthias Jürgens, Rüdiger P. Laubender, (unknown), Maria Weidinger, Julia Seiderer, Johanna Wagner, Martin Wetzke, Florian Beigel, Simone Pfennig, Johannes Stallhofer, Fabian Schnitzler, Cornelia Tillack, Peter Lohse, Burkhard Göke, Jürgen Glas, Thomas Ochsenkühn, Stephan Brand	142
8	Novel Genetic Risk Markers for Ulcerative Colitis in the IL2/IL21 Region Are in Epistasis With IL23R and Suggest a Common Genetic Background for Ulcerative Colitis and Celiac Disease 2009 ·The American Journal of Gastroenterology ·Jürgen Glas, Johannes Stallhofer, Stephan Ripke, Martin Wetzke, Simone Pfennig, Wolfram Klein, Jörg T. Epplen, Thomas Griga, U Schiemann, Martin Lacher, Sibylle Koletzko, Matthias Folwaczny, Peter Lohse, Burkhard Göke, Thomas Ochsenkühn, Bertram Müller‐Myhsok, Stephan Brand	63
9	GLP‐1 regulates gastroduodenal motility involving cholinergic pathways 2009 ·Neurogastroenterology & Motility ·Jörg Schirra, (unknown), Hans J. Woerle, (unknown), Martin Katschinski, Burkhard Göke	67
10	MMP-1 serum levels predict coronary atherosclerosis in humans 2009 ·Cardiovascular Diabetology ·Michael Lehrke, Martin Greif, Uli C. Broedl, Corinna Lebherz, Rüdiger P. Laubender, Alexander Becker, Franz von Ziegler, Janine Tittus, Maximilian Reiser, Christoph R. Becker, Burkhard Göke, Gerhard Steinbeck, Alexander Leber, Klaus G. Parhofer	62
11	The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial 2008 ·Diabetic Medicine ·Stefano Del Prato, Lawrence Blonde, L. Martínez, Burkhard Göke, Vincent Woo, Ann Millward, Ramón Gomis, (unknown), Thomas Strack, David Lawrence, Nick Freemantle, (unknown)	11
12	Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer 2006 ·Clinical Cancer Research ·Maike Wallner, Andreas Herbst, Andrea Behrens, Alexander Crispin, P Stieber, Burkhard Göke, R. Lamerz, Frank T. Kolligs	153
13	IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration 2006 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Stephan Brand, Florian Beigel, Torsten Olszak, Kathrin Zitzmann, Sören T. Eichhorst, Jan‐Michel Otte, Helmut M. Diepolder, Andreas Marquardt, Wolfgang Jagla, Andreas Popp, Stéphane Leclair, Karin A. Herrmann, Julia Seiderer, Thomas Ochsenkühn, Burkhard Göke, Christoph J. Auernhammer, Julia Dambacher	454
14	SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-λs IL-28A and IL-29 2005 ·Biochemical and Biophysical Research Communications ·Stephan Brand, Kathrin Zitzmann, Julia Dambacher, Florian Beigel, Torsten Olszak, George Vlotides, Sören T. Eichhorst, Burkhard Göke, Helmut M. Diepolder, Christoph J. Auernhammer	74
15	DRO1, a Gene Down-regulated by Oncogenes, Mediates Growth Inhibition in Colon and Pancreatic Cancer Cells 2004 ·Journal of Biological Chemistry ·Guido T. Bommer, (unknown), (unknown), (unknown), Sören T. Eichhorst, Thomas Brabletz, Gang Hu, Thomas Fröhlich, Georg J. Arnold, (unknown), Burkhard Göke, Eric R. Fearon, Frank T. Kolligs	49
16	DUG is a novel homologue of translation initiation factor 4G that binds eIF4A 2002 ·Biochemical and Biophysical Research Communications ·Alexandra Göke, Rüdiger Göke, (unknown), Heidi Trusheim, Harald Schmidt, Andreas Wilmen, Ruaidhrı́ J. Carmody, Burkhard Göke, Youhai H. Chen	79
17	Glucagon-like peptide-1: a potent regulator of food intake in humans 1999 ·Gut ·(unknown), Burkhard Göke, Jürgen Drewe, Pius Hildebrand, Sylvia Ketterer, (unknown), Sun Young Rha, David Conen, Christoph Beglinger	458
18	Tryptophan rich diet as a new approach to study the serotoninergic enteropancreatic axis. 1987 ·Gut ·Burkhard Göke, G. Richter, Volker Keim, R. Arnold	3
19	Effect of pancreatic atrophy and hypertrophy on the small intestine. 1987 ·Gut ·G Adler, (unknown), (unknown), Burkhard Göke, H. Lorenz‐Meyer, L. Herberg, R. Arnold	5
20	Effect of a Specific Serine Protease Inhibitor on the Rat Pancreas: Systemic Administration of Camostate and Exocrine Pancreatic Secretion 1984 ·Digestion ·Burkhard Göke, F. Stöckmann, R. Müller, P. G. Lankisch, W. Creutzfeldt	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact